Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:5.99.1.2 (
topoisomerase
)
9,166
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Batracylin (8-aminoisoindol[1,2-b]-quinasolin-12(10H)-one,
BAT
), a heterocyclic amine, was isolated in 1978 (NCI, Bethesda, USA) in the course of search for the new anticancer drugs. It showed high in vitro and in vivo anticancer activities against murine leukemia P338 and colon adenocarcinoma 38. Mechanism of action of
BAT
is still not completely clear. It was reported, that
BAT
is a
topoisomerase
II inhibitor and induces unscheduled DNA synthesis (UDS) in non-proliferating cells. Low solubility of
BAT
in water, high toxicity and necessity of high drug dosing are major limitations of its use as a chemotherapeutic drug. As a result, new
BAT
analogs were synthesized to improve its pharmacological properties. The modifications of
BAT
chemical structure include various substituents introduced to isoindoloquinazoline moiety (Cl, Br, NO(2), CH(2), NH(2), Me, CO(2)Me, OMe). It has been shown that the desamino derivative and the 8-aza analog of
BAT
retained the ability to inhibit
topoisomerase
II but did not induce unscheduled DNA synthesis. While less active than
BAT
, these analogs were cytotoxic toward CCRF-CEM leukemia cells. The isoindolo [2,1-a]benzimidazole derivatives were inactive as
topoisomerase
II inhibitors and, in general, failed to exhibit comparable antitumor activity or to induce unscheduled DNA synthesis. Batracylin was acylated with aminoacids, dipeptides, tripeptides to increase its solubility in water. Other modifications include introduction of nitrogen atom to ring A or D, extension of polycyclic ring 4, reduction of ring B from six- to five-membered one, and obtaining of benzimidazole, indole or derivatives containing a fucose ring. A series of novel
BAT
analogs bearing sugar residues and thiocarbonyl aminoacids, which provided better solubility in water and high cytostatic activity have been designed. Also, new azabatracylines, where aniline ring was replaced by pyridine or other substituted quinazolines, have been obtained. This paper reviews the most important approaches in batracylin synthesis and its analogs and presents structure-reactivity relationships for these compounds.
...
PMID:Novel approaches in the synthesis of batracylin and its analogs: rebirth of an old player? 2283 Mar 46